News | May 15, 2026
Senores Pharma doubles profit as sales surge 62%
Global specialty pipeline accelerates growth
Global specialty pipeline accelerates growth
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
We are building an AI-native operating system for pharma sales and distribution
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Shashwat Goenka takes over as Vice President of industry body
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Subscribe To Our Newsletter & Stay Updated
